Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
Components of the PANBioRa biomaterial risk assessment system








PROJECT NEWS
PANBioRA will be present at the virtual World Biomaterials Congress 2020!
Dr. Nihal Engin Vrana will hold a Keynote Lecture on personalised, multifunctional coatings for medical devices against infections and adverse immune reactions
Dr. Nihal Engin Vrana presents the PANBioRA project in a NanoAlb web seminar.
image credits: www.elveflow.com

Upcoming Events
T4M - Technology for Medical Devices is being postponed and will take place from 8 to 10 June 2021.
The Scandinavian Society for Biomaterials ScSB 2021 conference will be held as virtual event on 14th June 2021.
In 2021 the 26th Congress of ESB will take place online
Latest Tweets
